Fundraising FoxSignet Healthcare Partners — 2015 Investments
2 investments dated 2015 · listed companies and verified rows first · show all
Icon Bioscience develops biodegradable, sustained-release intraocular ophthalmic products using its proprietary Verisome drug delivery technology, targeting unmet needs in inflammation, glaucoma, and retinal disease treatment.
BiotechHealthtechMedical DevicesSunnyvale, US
David Tierney(Executive Officer, Director)in
BoardSong Toja(Director)William White(Director)Michael Hemric(Director)
Board seatJoyce Erony· per SEC Form D
Bionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules.
BiotechHealthtechPrinceton, US
Gaurav Mehrotra(Executive Officer)inVenkatachalam Krishnan(Executive Officer, Director)Lavesh Samtani(Executive Officer)
BoardJames Gale(Director)Carol S. Ben-Maimon(Director)Richard Van Duyne(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.